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al., 1999). This method requires the delivery to cancer-
ous cells of a foreign gene through local DNA injection,
or specific targeting with recombinant viral vectors. The
expression of the exogenous enzyme either results in
novel sensitivity of cells toward a compound or allows
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I-20132 Milan the administration of lower prodrug doses, thus reduc-
ing systemic toxicity. This approach has proven suc-Italy
cessful in several model systems (Hood et al., 2002;
Miyagi et al., 2003; Niculescu-Duvaz et al., 1999). Further
developments clearly depend on the identification ofSummary
novel, powerful enzymes for the conversion of the less
toxic FU derivatives, such as FUR, to the biologicallyEnzymes with nucleoside hydrolase (NH) activity are
active metabolites.crucial for salvaging nucleic acid components in pu-
Nucleoside phosphorylases (NPs) are the key en-rine auxotrophic protozoan parasites, but are also
zymes for nitrogenous base salvage in both prokaryotespresent in prokaryotes and higher eukaryotes. Here
and eukaryotes, catalyzing the phosphorolysis of thewe analyze the distribution of genes encoding for puta-
N-glycosidic bond in nucleosides to yield free base andtive NH proteins and characterize the yeiK gene prod-
ribose-1-phosphate (Krenitsky, 1967). Parasitic proto-uct from Escherichia coli as a pyrimidine-specific NH.
zoa such as trypanosomes are a notable exception,The crystal structure of YeiK to 1.7 A˚ defines the struc-
since they lack NP activities and recycle nucleobasestural basis for its substrate specificity and identifies
through a hydrolytic reaction catalyzed by highly effi-residues involved in the catalytic mechanism that dif-
cient nucleoside hydrolases (NHs) (Hammond and Gut-fer from both nonspecific and purine-specific NHs.
teridge, 1984; Versees and Steyaert, 2003). NHs fromLarge differences in the tetrameric quaternary struc-
various kinetoplastids have been extensively character-ture compared to nonspecific protozoan NHs are
ized, revealing the existence of two enzyme classes withbrought forth by minor differences in the interacting
distinct substrate specificities. Nonspecific NHs, whosesurfaces. The first structural and functional character-
epitome is the inosine-uridine-preferring (IU-NH) fromization of a nonparasitic, pyrimidine nucleoside-spe-
Crithidia fasciculata, hydrolyze efficiently both purinecific NH suggests a possible role for these enzymes
and pyrimidine nucleosides (Parkin et al., 1991), whilein the metabolism of tRNA nucleosides. The high cata-
purine-specific NHs (inosine-adenosine-guanosine-pre-lytic efficiency of YeiK toward 5-fluorouridine could be
ferring [IAG-NH]) display a strict specificity (Parkin, 1996;exploited for suicide gene therapy in cancer treatment.
Pelle et al., 1998; Versees et al., 2001). The first crystal
structure of the IU-NH from C. fasciculata identified a
Introduction unique open (,) fold displaying similarities to dinucleo-
tide binding proteins, but with distinct features evolved
Since its introduction in 1957 (Heidelberger et al., 1957), for the specific catalytic role (Degano et al., 1996). The
5-fluorouracil (FU) remains a cornerstone of the chemo- IU-NH complex with a transition state-like inhibitor re-
therapeutic intervention against solid tumors such as vealed a previously uncharacterized calcium ion bound
prostate (Curran, 2002), head-and-neck, colorectal (Go- to the enzyme active site, involved in both substrate
lomb, 1964; Haddad et al., 2003; Smorenburg et al., binding and polarization of a catalytic water nucleophile
2001), and breast cancer (Smorenburg et al., 2001). The (Degano et al., 1998). More recently, the structure of the
mechanism of action primarily involves the metabolic IAG-NH from Trypanosoma vivax confirmed a common
conversion of FU to 5-fluorodeoxyuridine monophos- framework for substrate binding in all NH enzymes
phate, which acts as a powerful inhibitor of thymidilate (Versees et al., 2001), including the divalent active site
synthase (Parker and Cheng, 1990), ultimately arresting ion. Several differences in the active site explained the
DNA replication. The low efficiency of endogenous structural basis for the exquisite purine specificity and
mammalian enzymes in converting FU to the active in- suggested a different mechanism for leaving group acti-
hibitor severely reduces the efficacy of this approach in vation based on aromatic stacking networks (Versees
patients. Indeed, the high doses of prodrug required for et al., 2002).
complete clearance of malignant cells often result in These structural elucidations pinpointed a consensus
high systemic toxicity (Malet-Martino et al., 2002). Other sequence formed by an N-terminal DXDXXXDD aspar-
FU derivatives, such as 5-fluorouridine (FUR), display tate cluster that is a fingerprint for NH enzymes. Several
significantly reduced toxicity and a facilitated uptake, genes encoding for putative NH proteins have been an-
but suffer from even lower metabolic conversion rates. notated in genomes from both prokaryotes and eukary-
Hence, the use of suicide gene therapy is being investi- otes based on the presence of this amino acidic motif.
gated in order to enhance the transformation in vivo of This finding raised the question whether these genes
these prodrugs to the active form (Niculescu-Duvaz et indeed encode for NH enzymes, and most importantly,
what their role is in organisms that recycle nitrogenous
bases via NP-catalyzed phosphorolysis. Here we char-*Correspondence: degano.massimo@hsr.it
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Figure 1. Primary Structures of Representa-
tive NH Proteins
Amino acid sequence alignments for 12 se-
lected putative NH proteins identified through
genomic searches, and previously character-
ized enzymes. Residue numbers are as in the
YeiK sequence. Top panel, the N-terminal re-
gion with the aspartate cluster involved in
binding of the active site Ca2 ion and activa-
tion of the water nucleophile conserved in all
NH proteins. Bottom, alignment of the region
containing the IU-NH His241, highlighted in
purple. Putative NH proteins from insects and
X. laevis lack the catalytic histidine and have a
conserved cysteine (green). IAG-NH enzymes
bear an aromatic residue (blue) involved in
stacking interactions with the purine ring. In
both panels, the protein residues involved
in interactions with the calcium ion or ribose
ring are highlighted in yellow.
acterize the primary structures of putative NH proteins This peptide includes the aspartate residue that com-
pletes the coordination sphere of the active site Ca2.from all kingdoms of life and identify further patterns
that relate to their different specificities. We cloned, The neighboring histidine has been proposed to act as
a proton donor for the hydrolytic reaction catalyzed byoverexpressed, and characterized one of the three
Escherichia coli NHs, the yeiK (RihB) gene product (Pet- the nonspecific IU-NH from C. fasciculata (Gopaul et al.,
1996), and its mutation to alanine abolishes activity in theersen and Moller, 2001). The YeiK protein is a novel
NH with absolute specificity for pyrimidine nucleosides URH1 uridine hydrolase from Saccharomyces cerevisiae
(Kurtz et al., 2002). Group I proteins are found in severalbearing both natural and nonnatural nitrogenous bases
(E.C. 3.2.2.8), including tRNA components. The crystal bacteria, eukaryotes, and plants. Group II sequences
have the catalytic histidine replaced by an aromatic resi-structure of YeiK to 1.7 A˚ resolution represents the first
structural characterization of a bacterial NH. The active due (tyrosine or tryptophan). The epitomes of this group
are the purine-specific NHs, such as the T. vivax andsite of the enzyme shows features in common with IU-
NHs, but with differences in surrounding residues that T. brucei brucei IAG-NH enzymes, and include homolo-
gous proteins from the nonparasitic bacilli Bacillus an-clarify the structural basis for its distinct substrate speci-
ficity. The tetrameric quaternary structure of YeiK also thracis and Oenococcus oeni. The third group includes
proteins from Aedes aegypti, Drosophila melanogaster,shares similarities with IU-NHs, but small differences in
the intermolecular contacts result in large changes in and Xenopus laevis which differ even further with a
XCDX sequence, thus including a Ca2-chelating aspar-the overall assembly. Structure-based active site muta-
genesis confirms a catalytic mechanism distinct from tate, but having a conserved cysteine at the location of
the IU-NH His241. Putative enzymes from group III couldother NHs, with specific amino acid residues involved
in leaving group activation. A possible use of the enzyme hence reveal a different mechanism for N-glycosidic
bond hydrolysis or display yet uncharacterized sub-in cancer gene directed enzyme prodrug therapy (Ni-
culescu-Duvaz et al., 1999) emerges from the high cata- strate specificities. Thus, NH proteins are widely distrib-
uted throughout kingdoms and are not exclusive of or-lytic efficiency of YeiK toward FUR.
ganisms defective in purine base biosynthesis such as
protozoa. What are then the specificities and structural
Results characteristics of these annotated NH proteins?
Distribution and Characteristics of NH Genes
Homology-based database searches identified more YeiK Is a Pyrimidine-Specific NH
The E. coli yeiK gene product, which we identifiedthan 130 different genes that encode for putative NH-
like proteins bearing the N-terminal aspartate cluster. through database searches, was previously shown to
increase nucleosidase activity in total cell extracts (Pet-These proteins range in primary structure composition
from 300 to 360 amino acids and can be subdivided in ersen and Moller, 2001). Recombinant YeiK runs as a
single band on a denaturing SDS-PAGE gel with an ap-three distinct groups (Figure 1). Group I proteins are the
most represented and bear a conserved {V,I,L,M}HD parent molecular weight of 33 kDa. The purified protein
elutes from size exclusion chromatography at a reten-{P,A,L} tetrapeptide sequence approximately 230 amino
acids downstream of the N-terminal aspartate cluster. tion volume corresponding to a molecular mass of 143
Structure of a Pyrimidine Nucleoside Hydrolase
741
Table 1. Kinetic Parameters of YeiK and Other NHs
YeiK E. coli IU-NH C. fasciculata IAG-NH T. vivax
kcat (s1) KM (M) kcat/KM (105 M1 s1) kcat (s1) KM (M) kcat (s1) KM (M)
Uridine 4.7  0.1 142  8 0.33  0.02 255 1220 0.02 586
Cytidine 11.6  1.8 532  101 0.22  0.07 36 4700 0.3 925
5-Fluorouridine 14.7  1.0 128  15 1.14  0.21 — — — —
5-Bromouridine 30.8  1.4 186  13 1.66  0.2 — — — —
5-Iodouridine 42.7  4.4 220  34 1.94  0.5 — — — —
5-Methyluridine 25.5  4.0 329  69 0.77  0.28 380 1300 — —
Inosine — — — 28 380 5.2 5.4
Adenosine — — — 4.3 460 1.5 8.5
Guanosine — — — 1.5 420 1.9 3.8
Steady-state kinetic parameters for YeiK were determined as described in the Experimental Procedures. kcat and KM values for the IU-NH and
IAG-NH enzymes were taken from Horenstein et al. (1991) and Versees et al. (2001).
kDa, hence consistent with a homotetrameric quater- implies either the presence of structural constraints, ex-
cluding the larger purine rings from the active site, ornary structure. This result is further supported by dy-
namic light scattering measurements, which reproduc- the absence of specific protein residues for productive
binding interactions. What is then the structural basisibly indicate a hydrodynamic radius of 4.8  0.2 nm and
a deduced molecular mass of 137 kDa. We found no for the pyrimidine-specific activity of YeiK?
evidence of monomeric or dimeric YeiK with either tech-
nique, thus suggesting a strong association between Crystal Structure of YeiK to 1.7 A˚
the subunits. Hence, YeiK is a homotetrameric protein, We determined the crystal structure of YeiK to 1.7 A˚
similar to the characterized protozoan IU-NHs (Parkin using X-ray diffraction and the molecular replacement
et al., 1991; Shi et al., 1999), and does not display the technique (Table 2). The overall structure of the YeiK
suggested dynamic monomer-dimer equilibrium ob- monomer resembles the NH fold (Degano et al., 1996),
served for the IAG-NH from T. vivax (Versees et al., 2001). with an open (,) structure (Figure 2). The core eight-
The enzymatic characterization defines YeiK as a py- stranded  sheet, composed by seven parallel and one
rimidine-specific NH (Table 1). Remarkably, the catalytic antiparallel strands, is topped by a helical “cap” com-
efficiency of YeiK toward inosine, adenosine, or guano-
sine is at least 1000-fold below that for uridine; thus,
the enzyme is substantially inactive toward these sub- Table 2. Summary of Crystallographic Data
strates. Deoxynucleosides are also not substrates for
Data CollectionYeiK, confirming a common characteristic for all NHs
Wavelength (A˚) 0.933in discriminating the presence of all ribose hydroxyls
Resolution range (A˚) 81.6–1.7 (1.79–1.70)a(Estupinan and Schramm, 1994; Parkin et al., 1991; Pelle
Number of observations 239,378 (23,873)et al., 1998). Instead, all the 5-substituted pyrimidine
Unique reflections 122,470 (12,529)nucleosides tested are substrates, suggesting a struc-
Completeness (%) 91.5 (63.8)
tural tolerance of the enzyme toward chemical groups I/(I)	 9.5 (3.0)
departing from the base at this position. The rate of bRsym 0.046 (0.221)
cRmeas 0.065 (0.312)catalysis of YeiK changes as a function of the C5-sub-
stituent electronegativity, implying that a negative Refinement Statistics
charge probably develops at the nitrogenous base along
Resolution range (A˚) 43.8–1.70the reaction coordinate (Table 1). Finally, 3-deazauridine
Number of reflections (Fobs	0) 121,220is not a substrate to the detection level of 104 the rate dR 0.153
for uridine, highlighting a critical role of the N3 atom of eRfree 0.170
pyrimidines in the catalytic mechanism. To confirm that Rmsd bonds (A˚) 0.007
Rmsd angles (
) 1.31YeiK is a Ca2-dependent NH, we measured the activity
of the enzyme after incubation with EGTA. The activity Average Temperature Factors (A˚2)
toward the substrate uridine was reduced to less than
Protein 13.30.1% and could be partially restored by addition of ex-
Ions 14.1
cess calcium (data not shown). Thus, the Ca2 of YeiK Solvent 30.4
is required in maintaining the active site structure and Glycerol 27.9
is crucial for the binding of substrate or polarization of
a Numbers in parentheses refer to the highest resolution shell.
the nucleophilic water molecule. The KM values deter- b Rsym  hi|Ii,h  Ih	|/hiIi,h, where Ii,h is the ith measurement of
mined for the substrates tested (Table 1) indicate that reflection h, and the summations include all observed reflections.
YeiK binds pyrimidine nucleosides with higher affinities c Rmeas, multiplicity-weighted Rsym.
d R  h||Fo|  |Fc||/h|Fo|, where the summation is extended overcompared to the IU-NH enzymes (Parkin et al., 1991;
all unique reflections to the specified resolution.Shi et al., 1999), suggesting an evolution of the active
e Rfree, R factor calculated using 1247 randomly chosen reflectionssite for accommodation of the pyrimidine base. Con-
(1%) set aside from all stages of refinement.
versely, the inactivity toward purine nucleosides clearly
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Figure 2. Tertiary and Quaternary Structure
of YeiK
(A) Stereo view of the three-dimensional
structure of YeiK as a ribbon diagram, with 
strands colored blue and  helices in pink.
The active site Ca2 is depicted as a yellow
sphere.
(B) Tetrameric structure of YeiK. One interac-
tion surface is composed of the loops con-
necting strand 5 to helix 5, helix 9 to 10,
and strand 8 to 9 shown. Two dimers as-
semble into a tetramer through a composite
surface comprising residues from strands 8
and 9, the 6 helix, and the loops connecting
strands 3 to helix 3, and strand 4 to helix
4. The IAG-NH from T. vivax instead dimer-
izes through a different surface composed by
helices 3, 9, and 10. Figures were gener-
ated with the programs MOLSCRIPT (Kraulis,
1991) and RASTER3D (Merritt and Murhpy,
1994).
posed by four  helices and flanked by two antiparallel Hence, YeiK displays the highest structural similarity
to the IU-NH enzymes so far characterized. The rmsd strands involved in quaternary structure assembly.
The four independent molecules of YeiK in the crystal between the IU-NH transition state complex structure
(PDB code 2MAS), which undergoes large conforma-unit cell are essentially identical, with an average root-
mean-square distance (rmsd) of 0.17 A˚. Limited main tional changes upon inhibitor binding, and YeiK is 0.93 A˚
for 292 atoms, suggesting that the YeiK molecules inchain differences are observed at the crossover loop
linking 3 to 3 (amino acids 90–100), and the C-terminal the crystal are in the “closed” form. The presence of a
glycerol molecule from the cryoprotection buffer boundresidues of helix 9 (amino acids 224–234). Amino acids
90–100 are highly flexible in all IU-NH structures, re- to each active site is the likely cause for the transition
from the “open” to the “closed” form in YeiK. Hence,flecting a possible functional role in substrate entry. The
terminal portion of helix 9 is also highly flexible and the binding of ligands at this subsite probably represents
the molecular switch for the conformational changeswas shown to undergo a large conformational change
in the IU-NH transition state complex. Thus, the small observed in the NH enzymes.
All protozoan NHs characterized have a dimeric, tri-structural differences in the four independent YeiK mole-
cules in the crystal probably reflect a structural flexibility meric, or tetrameric quaternary structure whose role is
still debated. The YeiK enzyme homotetramer exhibitsof the enzyme that could play a role in substrate binding
and catalysis. The rmsd between YeiK and the unli- D2 (222) point group symmetry (Figure 2B), with intermo-
lecular contacts mediated by the same structural ele-ganded IU-NHs from C. fasciculata (PDB code 1MAS),
Leishmania major (1EZR), and the IAG-NH from T. vivax ments involved in tetramer formation in IU-NHs (Degano
et al., 1998; Shi et al., 1999). However, a different orienta-(1HOZ) are 1.13 A˚ for 276, 1.03 A˚ for 273, and 1.52 A˚
for 251 structurally equivalent C atoms, respectively. tion of strand 9 (Figure 3A) of YeiK allows a more exten-
Structure of a Pyrimidine Nucleoside Hydrolase
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Figure 3. Structural features of YeiK
(A) Structural comparison between the YeiK
and IU-NH transition state complex mono-
mers. The arrows highlight the major differ-
ences in main chain conformation at the loop
3-3 (C1 in the figure), the C terminus of
helix 9 (C2), and the loop between 8 and
9, involved in quaternary structure assem-
bly (C3).
(B) Stereo view of a sigmaa-weighted “shake”
omit (2Fo-Fc,φc) electron density map to 1.7 A˚
of the active site of YeiK contoured at 2.0.
Superimposed is the refined model. The pro-
tein residues, calcium ion, glycerol, and sol-
vent molecules were removed, and the model
coordinates were randomly perturbed to a
final rmsd of 0.4 A˚ before phase calculation.
Figures were generated with DINO (http://
www.dino3d.org).
sive interaction between monomers via a hydrophobic with the catalytic ion and involved in the binding of the
ribosyl moiety of nucleosides. The Ca2 ion is octacoor-surface formed by residues Leu278, Val280, and Leu281.
These differences result in a significant increase in total dinated by two water molecules, one glycerol molecule,
four carboxylate oxygens from side chains of Asp11,buried surface at both monomer-monomer interaction
surfaces (891 and 1071 A˚2 versus 851 and 754 A˚2). As a Asp16, and Asp240, and the main chain carbonyl oxygen
of Val124. All residues shown to interact with the ribosylresult, when two monomers from the IU-NH and YeiK
tetramers are superimposed with an rmsd of 0.93 A˚, the moiety in NHs are also strictly conserved in YeiK (Figure
4A). Thus, the overall protein architecture for ribosylother subunits have calculated rmsds of 4.07, 4.44, and
9.17 A˚ for 292 C atoms from their counterparts. For binding is conserved in the pyrimidine-specific NH YeiK.
In contrast, significant diversity is observed on the activecomparison, when the same operation is carried out
between the structures of the IU-NHs from C. fasciculata site walls that provide interactions with the nitrogenous
base of the substrates, determining the substrate speci-and L. major, the rmsd values are 1.26, 1.28, and 2.61 A˚
for 298 C atoms. Thus, while the same tertiary structure ficity. The side chains of residues Thr223, Gln227, and
Tyr231 from helix 9, and His239 line a hydrophilic sub-elements are responsible for the tetramerization of YeiK
and IU-NHs, the resulting assembly differs markedly be- site with high potential for hydrogen bonding interac-
tions. The opposite portion of the cavity is more hy-tween the two proteins.
drophobic in character, with the side chains of Phe159,
Phe165, Tyr231, Asn80, Ile81, and His82 contributing toStructural Basis for Pyrimidine
Nucleoside Specificity its surface. The active site volume of 41 A˚3 compares
to the 61 A˚3 of the Crithidia IU-NH. This reduction isThe active site of NHs is localized at the topological
switchpoint of the core  sheet, in a crevice between largely due to the position of Tyr231, protruding more
into the active site compared to the Arg233 of the proto-strands 1 and 4 (Degano et al., 1996). The bottom of
the active site of YeiK is lined by residues interacting zoan enzyme. Nevertheless, the size of the active site
Structure
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Figure 4. Active Site of YeiK, and a Model for
Enzyme-Substrate Interactions
(A) Active site of YeiK. The residues coordi-
nating the calcium ion, and conserved resi-
dues interacting with the ribose ring in NHs,
are colored in light blue. Protein side chains
with the potential of interaction with the py-
rimidine base of nucleosides are depicted in
cyan. The interactions of the octacoordinated
calcium ion with protein, water, and glycerol
molecules are drawn as dashed lines.
(B) A model for the interactions between YeiK
and pyrimidine nucleosides. The structures
of YeiK and IU-NH from C. fasciculata were
superimposed as described in the text. Resi-
dues from YeiK and IU-NH are colored light
blue and pink, respectively. The aniline ring
of the inhibitor is numbered as the pyrimi-
dine base in the proposed binding mode. Fig-
ures were generated with DINO (http://www.
dino3d.org).
portion that is presumed to bind the nitrogenous base binding site is mostly lined by hydrophobic amino acids
(Figure 4B). These residues could interact via van deris comparable in size to that observed in the IU-NH.
Thus, the pyrimidine nucleoside specificity of YeiK must Waals’ interactions with substituents at position 5 of
the pyrimidine ring, such as the halogens tested in thearise from the presence of amino acid residues that
prevent key interaction with the purine bases. kinetic studies. However, they lack the potential for spe-
cific interactions with the polar atoms of the pyrimidineThe structure of the complex of IU-NH from C. fascicu-
lata with the transition state-like inhibitor p-aminophenyl base, unlike the hydrophilic residues at the opposite
subsite.iminoribitol provides a template for modeling the inter-
actions of pyrimidine nucleosides with YeiK (Figure 4B).
A superposition of the two active sites positions the Implications for the Catalytic Mechanism
of Pyrimidine Nucleosidasesribose oxygens of the inhibitor on one ordered water
and a glycerol molecule interacting with the Ca2 ion. The IU-NH enzymes reach the transition state of the
hydrolytic reaction primarily via the distortion of the ribo-The glycerol molecule superimposes with the O3, C3,
C4, O4, C5, and O5 of the ribosyl moiety with an syl moiety of the nucleoside (Horenstein et al., 1991)
toward the geometry of an oxycarbenium ion. The oxy-rmsd of 0.18 A˚, thus mimicking closely the protein-ribose
interactions. The pyrimidine base is surrounded by resi- carbenium ion is stabilized by the negatively charged
aspartates and a glutamate, and by a intramoleculardues His82, Gln227, Tyr231, and His239. Van der Waals’
interactions are possible between the pyrimidine ring neighboring group interaction with the 5-hydroxyl of the
ribose. The water molecule in the Ca2 octacoordinationand the side chain of Ile81. The imidazolium moiety of
His239 could interact with the carbonyl protruding from sphere is presumed to perform the nucleophilic attack
at the ribose C1 atom, with the second aspartate of theposition 2 of the pyrimidine ring. Gln227 is poised for a
bidentate hydrogen bond to the N3 nitrogen and the O4 N-terminal cluster acting as a general base (Degano et
al., 1998). The similarity between the YeiK and IU-NHcarbonyl of uridine. This carbonyl oxygen is also 3.5 A˚
from the hydroxyl of Tyr231. The opposite portion of the active sites suggests a similar catalytic mechanism. To-
Structure of a Pyrimidine Nucleoside Hydrolase
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the existence of alternative proton donors in the YeiK-Table 3. Kinetic Analysis of Site-Specific YeiK Mutants
catalyzed pyrimidine nucleoside hydrolysis. Thus, the
Enzyme kcat (s1) KM (M) mutagenesis data support the proposed mode for sub-
YeiK 4.7  0.1 142  8 strate binding, with key interactions provided by His82
His239Ala 4.4  0.2 1900  100 and His239, and show how different YeiK residues can
His82Asn 15.5  1.1 345  55
potentially contribute as proton donors to N-glycosidic
Steady-state kinetic characterization of recombinant YeiK, His239Ala, bond cleavage.
and His82Asn mutants. Parameters were determined as described
in the Experimental Procedures using uridine as substrate.
Discussion
Homology-based searches identified NH-like genes ingether with an enzyme-activated water nucleophile, a
general acid is required to counterbalance the negative several genomes, demonstrating a widespread distribu-
tion in prokaryotes and eukaryotes. The characteristicscharge developing at the leaving group during the reac-
tion. In the model for YeiK-substrate interactions (Figure of these putative NH proteins include (1) the presence of
an aspartate-rich {D,N}XDXXXDD fingerprint sequence4B), the side chains of Gln227, Tyr231, and His239 are
properly positioned for hydrogen bonding interactions near the N terminus of the putative protein; (2) an aspar-
tate residue located between 225 to 235 amino acidswith the O2 and O4 carbonyls of uridine, and the N3
pyrimidine nitrogen. His239 could donate a proton to downstream of the consensus sequence, completing
the Ca2 coordination sphere; and (3) a calculated mo-the N3 nitrogen or O2 oxygen of uridine. The inactivity
of YeiK toward 3-deazauridine underlines the impor- lecular weight in the 31–42 kDa range. The presence of
a homolog of the His82 or His239 residue of YeiK is nottance of the pyrimidine N3 atom in catalysis, either as
a proton acceptor or involved in specific interactions a strict requirement, since, for instance, IAG-NHs use a
different mechanism for proton transfer. The primarywith the enzyme to correctly orient the substrate. His82
is within 3.2 A˚ from the pyrimidine nucleoside N1 or O2 structures of the putative NH proteins annotated in dif-
ferent genomes clearly cluster in three groups. The func-atom and thus in the appropriate orientation for proton-
ation, as a partial negative charge can be delocalized tional data obtained on these proteins suggest that
group I proteins include nonspecific and pyrimidine-between these positions. The importance of counterbal-
ancing this charge at the pyrimidine ring is apparent specific NHs, while group II comprises the purine-spe-
cific enzymes. The third group of NH proteins is yetfrom the steady-state kinetics with substituted uridines.
The increase of kcat in uridines with different halogens uncharacterized, and it is intriguing that they pertain to
multicellular organisms, such as insects. The presenceat C5 correlates with the inductive effects of the substit-
uents in stabilizing a negative charge (Table 1). Indeed, of a conserved His and Cys at the binding site in this
subfamily anticipates significant differences in the cata-the acidity of both N1 and N3 protons of uracil is sequen-
tially increased by a methyl, hydrogen, or fluorine group lytic mechanism.
Three genes in E. coli have been recently shown toat the C5 position of the pyrimidine ring (Jang et al.,
2001). Hence, the stabilization of the negative charge in encode for NH enzymes with different specificities (Pet-
ersen and Moller, 2001). The yaaF gene product wasthe leaving group lowers the energy barrier to reach
the transition state and improves the catalytic rate. The defined as a nonspecific IU-NH enzyme, while overex-
pression of YeiK and YbeK augmented pyrimidinemeasured kcat for 5-methyluridine, intermediate between
5-fluoro and 5-bromouridine, also indicates that other nucleosidase activities. The present study finely charac-
terizes the substrate specificity and kinetic propertiessubstrate-enzyme interactions contribute to transition
state stabilization. of YeiK as a pyrimidine-specific NH. Purine nucleosides
are not hydrolyzed to a measurable extent, reflectingWe generated two site-specific mutants (Table 3) to
validate our hypotheses on the involvement of His82 a structural evolution of the active site to select for
pyrimidine but not purine bases as substrates for theand His239 in the catalytic mechanism of YeiK. The
His239Ala mutant displays a dramatic increase in KM hydrolytic reaction. The variations in the turnover num-
ber for the differently substituted pyrimidine rings corre-for the substrate uridine (1.9 mM), but a substantially
unchanged kcat of 4.4 s1. The increase in KM supports late with the ability of the substituents to stabilize a
negative charge at the nitrogenous base. Hence, a likelythe view that His239 is largely involved in the binding
of the substrate and supports the model where the N3 mechanism for the hydrolytic reaction involves the initial
distortion of the ribosyl moiety toward an oxycarbeniumand O2 atoms of uridine are in contact with this residue.
However, His239 is clearly not a unique proton donor ion, with a partial negative charge in the nitrogenous
base. The pyrimidine base can be oriented in a catalyti-in the hydrolysis of uridine catalyzed by YeiK since kcat
is unchanged by the mutation. A His82Asn mutation was cally competent conformation through hydrogen bond-
ing interactions with the residue Gln227 to the N3 nitro-engineered to produce an enzyme that retains hydrogen
bonding capabilities at this position but cannot transfer gen and O4 carbonyl oxygen, and with His239 to the O2
carbonyl oxygen. These interactions, together with thea proton to the leaving group at physiological pH values.
This variation causes a smaller increase in KM (345 M) distortion toward a C4-endo conformation of the fu-
ranose ring, could force the plane of the pyrimidine ringcompared to the His239Ala mutant, consistent with the
hypothesis that the interactions between this residue in a syn orientation that allows the approach of the
imidazole moiety of His82 within close distance to theand the substrate are important for binding. However,
the unexpected increase in kcat to 15.5 s1 suggests N1 and O2 atoms. The proton could be transferred to
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Figure 5. A Possible Application for Pyrimi-
dine-Specific NHs in Cancer Suicide Gene
Therapy
The conversion of the fluorouracil prodrug
5-fluorouridine is hampered by the low effi-
ciency of endogenous mammalian enzymes
in both enzymatic conversions toward the
5-FUMP metabolite. Localized delivery of
genes encoding for enzymes with highly spe-
cific activity toward these prodrugs (NHs and
UPRT [uracil phosphoribosyl transferase])
could improve the selective killing of cancer
cells by lowering the threshold dose required
for inhibition of thymidylate biosynthesis.
either the O2 atom, and subsequently tautomerized to that could not be met by the YeiK active site without
significant conformational changes. However, nonspe-the lactame form, or directly to the N1 p orbital. Hence
this catalytic mechanism suggests a different involve- cific NHs, in particular the E. coli yaaF gene product,
are candidates for the degradation of such nucleosides,ment of YeiK in pyrimidine nucleoside hydrolysis, where
His82 could also act as a general acid. His239 could including the ones bearing modified purine bases. Thus,
nonspecific and pyrimidine-specific NHs found in non-instead steer the base in a catalytically competent con-
formation via hydrogen bonding interactions and stabi- parasitic organisms could provide a joint action for the
breakdown of the unusual nucleosides found in tRNAlize the delocalized negative charge in the pyrimidine
ring. The properties of site-specific mutants of YeiK are molecules.
Gene-directed enzyme prodrug therapy is a promisingconsistent with this hypothesis, since the His239Ala mu-
tant displays a 10-fold higher KM for uridine but an un- two-step treatment for solid malignant tumors. In the
first step, the gene for a foreign enzyme is administeredchanged kcat. Moreover, the activity of the His82Asn mu-
tant suggests that different active site residues in YeiK and directed to the tumor, where it may be expressed
using specific transcriptional elements. In the secondcan act as general acid in catalysis. Finally, the finding
that the His82Asn mutant displays a higher turnover step, prodrugs are administered and activated by the
foreign enzyme expressed at the tumor. The high effi-number compared to the wild-type enzyme could indi-
cate that the rate-limiting step in the YeiK-catalyzed ciency of YeiK in converting FUR to FU prompts a valida-
tion of this bacterial gene product as a candidate for areaction is not the N-glycosidic bond cleavage but, for
instance, product release, as recently observed for the similar therapeutic approach (Figure 5). In fact, fluoro-
nucleosides are taken up by cells through nucleosideIAG-NH (Vandemeulebroucke et al., 2003). Further stud-
ies using pre-steady-state kinetic measurements are re- transporters (Desmoulin et al., 2002), and their bioavail-
ability is not hampered by multidrug resistance genequired to confirm this hypothesis.
The presence of three NH genes in the E. coli genome products, unlike fluorinated nucleobases such as FU or
fluorocytosine. In order to bypass both limiting steps in(Petersen and Moller, 2001), and at least one in several
other prokaryotes and eukaryotes (Aldritt et al., 1985; FUR activation in mammalian cells, nucleoside hydroly-
sis and phosphoribosyl transfer, we constructed a chi-Canale-Parola and Kidder, 1982; Chu and West, 1990;
Gero et al., 2000; Terada et al., 1967; Todd et al., 2003), meric, bifunctional NH-UPRT enzyme (B.G. and M.D.,
unpublished data). This construct encodes for both en-raises the question of their physiological and functional
role. Bacteria can recycle purine and pyrimidine bases zymatic activities required for the generation of the ac-
tive 5-FUMP nucleotide (Figure 5) and allows the deliverythrough glycosidic bond cleavage catalyzed by NPs,
and hence do not require NHs for the same action. The of a single gene product that efficiently catalyzes the
convertion of FUR to 5-FUMP. FUR-mediated cytotoxic-viability of URH1 knockout yeast strains (Kurtz et al.,
2002) also suggests a redundant role of NH enzymes, ity is present even in the absence of exogenous genes,
and the systemic toxicity is largely due to the high dosesat least under normal growth conditions. Thus, the three
E. coli NHs must play a highly specialized role in the required for sufficient activation and anticancer activity.
The cells transfected with the highly efficient NH-UPRTcell. One possible yet unexplored role for nonprotozoan
NHs could be an involvement in the degradation of modi- enzyme will require much lower doses of prodrug for
efficient inhibition of DNA synthesis, thus allowing selec-fied nucleosides found in tRNA, such as dihydrouridine,
thiouridine, or 3-methylcytidine. The efficient turnover of tive killing of cancerous cells. The high turnover number
of YeiK for the substrate FUR is coupled to a higher KMthe tRNA constituent ribosylthymidine (5-methyluridine)
by YeiK supports this hypothesis. Other tRNA nucleo- compared to the naturally occurring nucleoside uridine.
Hence, initial efforts should be directed to the engi-sides are characterized by functional groups linked to
the pyrimidine base ring, such as the uridine derivative neering of YeiK mutants with higher affinity toward FUR.
Based on the present structure of YeiK, higher specific-lysidine with a lysine residue departing from the C2 car-
bon atom. These modifications pose steric constraints ity could be achieved by altering the hydrophobic site
Structure of a Pyrimidine Nucleoside Hydrolase
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Kinetic parameters were obtained by direct fit to the Michaelis-where the halogen atom is likely accommodated. This
Menten equation using the program DYNAFIT (Kuzmic, 1996).site is lined by the aromatic rings of residues Phe159,
Phe165, and Tyr231 and the side chain of Asn80. Halo-
gen atoms in proteins have been observed in both hy- Crystallization and Data Collection
Plate-shaped crystals were grown using the hanging drop vapordrophobic and polar environments. Hence, mutations
diffusion method from 100 mM Tris (pH 8.5), 200 mM NaCl, andintroducing in the cavity specific hydrogen bonding do-
25% PEG 3350. The crystals were transferred to an artificial mothernors for the fluorine are likely to selectively increase the
liquor containing 25% glycerol for cryoprotection, and flash-cooled
affinity of YeiK for FUR and result in even increased in a nitrogen stream at 100 K. The crystals were triclinic in the space
catalytic efficiency toward this prodrug. Alternatively, group P1 with unit cell constants a  44.81 A˚, b  85.71 A˚, c 
the fit between the fluorine atom and the binding cavity 90.68 A˚,   112.95
,   101.95
,   85.92
, and diffracted to
1.5 A˚ at beamline ID14-EH2 of the European Synchrotron Radiationcould be enhanced through substitution of the Phe resi-
Facility. The unit cell volume is consistent with one YeiK tetramerdues with short-chain aliphatic amino acids. Experi-
in the crystal asymmetric unit with a Matthews’ coefficient of 2.3 A˚3/ments are currently underway using mutated YeiK en-
Da, corresponding to 43% solvent content. Oscillation data were
zymes in fusion with the E. coli UPRT to enhance in vitro indexed, integrated with MOSFLM (Leslie, 1992), scaled, and re-
the sensitivity of cells to these chemotherapeutic duced with SCALA (CCP4, 1994) (Table 2).
agents. The assessment of YeiK as a remarkably effi-
cient activator of the widely used anticancer prodrug
Structure Determination and RefinementFUR paves the way for its employment in a novel gene-
We determined the crystal structure of YeiK with the molecular
directed enzyme prodrug therapy. replacement technique using the native IU-NH monomer structure
(PDB code 1MAS) as a search model, after removal of all solvent
Experimental Procedures molecules and ions. Four rotation and translation function solutions
were identified using the program MOLREP (Vagin and Isupov, 2001)
Bioinformatic Analysis with a cumulative correlation coefficient and R factor of 0.231 and
The program BLAST (http://www.ncbi.nlm.gov/blast) was used to 0.552, respectively. The R factor to 3.0 A˚ after rigid body refinement
search existing databases for open reading frames encoding for was 0.472. A sigmaa-weighted (2Fo-Fc, φc) electron density map to
proteins homologous to the IU-NH from C. fasciculata. Translated 1.7 A˚ clearly showed the loop connecting strand 3 and helix 3,
gene sequences, ESTs, or protein sequences were aligned using the which could not be traced in the IU-NH electron density maps (De-
program CLUSTALW (http://www.ebi.ac.uk/clustalw/) with default gano et al., 1996), and the presence of an electron dense ion coordi-
parameters. nated by the active site aspartates. The structure was automatically
rebuilt using ARP/wARP (Perrakis et al., 1999), and the sequence
DNA Cloning, Mutagenesis, Protein Expression, was manually assigned through inspection of electron density maps.
and Purification The rebuilt model had an R factor of 0.34 calculated using data to
The 919 bp yeiK gene was amplified by polymerase chain reaction 1.7 A˚. Refinement of the model was performed in cycles of manual
using the DeepVent proofreading DNA polymerase, gene-specific rebuilding in sigmaa-weighted (2Fo-Fc, φc) and (Fo-Fc, φc) electron
primers including the NdeI and EcoRI restriction sites, and genomic density maps using the program O (Jones et al., 1991), followed
DNA from the K12 derivative DH5 strain as template. The yeiK by maximum likelihood positional and isotropic temperature factor
gene was subcloned into the expression vector pET28b in fusion refinement as implemented in REFMAC5 (Murshudov et al., 1997).
with a N-terminal histidine tag. Site-specific mutants were generated Only variations in the model that resulted in similar decreases in
with polymerase chain reaction and DpnI selection (Weiner et al., both R factor and Rfree after refinement were implemented. Tight main
1994). All clones were sequenced on both DNA strands using the chain and loose side chain noncrystallographic symmetry restraints
automated dideoxy method. were imposed throughout refinement, except for the loop regions
The pET28-YEIK plasmid was transformed into BL21(DE3) compe- 90–100 and 224–234 of each molecule, which differ in the indepen-
tent cells for protein production. Cells were grown at 37
C in LB dent molecules. This combination of restraints yielded the lowest
medium to OD600  0.6, and protein expression was induced by combination of R and Rfree. Solvent molecules were automatically
addition of 0.5 mM isopropyl -D-1 thiogalactopyranoside. Cells added to difference electron density greater than 4 after the R
were harvested after 3 hr by centrifugation and disrupted by sonica- factor decreased below 0.22 and were maintained in the model
tion. Ni-NTA resin was added to the clear supernatant, and bound when their B factor was less than 50 A˚2 after refinement. The aniso-
proteins were eluted with 0.5 M Imidazole. Affinity-purified YeiK was tropic motion for each individual protein chain was modeled with
digested overnight at room temperature with thrombin at a ratio of the translation, libration, and screw axis displacement tensors (Winn
1:1500 w/w. The digested protein was further purified by gel filtration et al., 2001). The final model contains four YeiK subunits from residue
chromatography on a Superdex 200 column. Native enzyme prepa- 3 to 310, four calcium ions, 1055 solvent molecules, and 17 glycerol
rations typically have a specific activity of 105 mol/min·mg with molecules from the cryocooling buffer. The final R factor and Rfree
uridine as substrate. Dynamic light scattering measurements were are 0.153 and 0.170, respectively. All protein residues are within
performed on a DynaPro MS/X instrument with temperature control the allowed regions of a Ramachandran plot as calculated with
(Protein Solutions). Data collection and deconvolution were per- PROCHECK (Laskowski et al., 1993), with 91% in the most favored
formed using the DYNAMICS V6 software. regions. Root-mean-square distance (rmsd) calculations were per-
formed with the program LSQMAN (Kleywegt and Jones, 1997).
Enzymatic Activity Buried surface areas and active site volumes were calculated with
The NH colorimetric test was performed as previously described the programs SC (Lawrence and Colman, 1993) and VOIDOO
(Parkin et al., 1991). Ca2-free YeiK was obtained by 1 hr incubation (Kleywegt and Jones, 1994), respectively.
with 0.5 mM EGTA at 4
C, followed by dialysis against metal-free
20 mM Tris buffer at pH 7.3. Kinetic measurements were performed
on a Beckman DU-70 UV spectrophotometer at 37
C. Progress of Acknowledgments
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